Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Becky AS. Bibby"'
Autor:
Amy M. Buckley, Becky AS. Bibby, Margaret R. Dunne, Susan A. Kennedy, Maria B. Davern, Breandán N. Kennedy, Stephen G. Maher, Jacintha O’Sullivan
Publikováno v:
Pharmaceuticals, Vol 12, Iss 1, p 33 (2019)
Cisplatin (cis-diamminedichloroplatinum) is widely used for the treatment of solid malignancies; however, the development of chemoresistance hinders the success of this chemotherapeutic in the clinic. This study provides novel insights into the molec
Externí odkaz:
https://doaj.org/article/8dc5795466d74bd3a581849084cb514b
Autor:
Eimear Mylod, Ellen Mckenna, Maria Davern, Martin P Barr, Noel E Donlon, Becky AS Bibby, Anshul Bhardwaj, John V Reynolds, Joanne Lysaght, Stephen G. Maher, Melissa J. Conroy
Publikováno v:
Clinical and Experimental Medicine. 23:411-425
Introduction: The majority of oesophageal adenocarcinoma (OAC) patients do not respond to multimodal treatment regimens and face dismal survival rates. Natural killer (NK) cells are crucial anti-tumour immune cells, and this study investigated the su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::719b0d3baec4e9a4cb3c837601267483
https://doi.org/10.1007/s10238-022-00811-6
https://doi.org/10.1007/s10238-022-00811-6
Autor:
Lingjian Yang, Patrick Shenjere, James P Wylie, Becky A.S. Bibby, Joely J Irlam, Helen R Valentine, Laura-Jane Forker, Michael G Leahy, Ananya Choudhury, Catharine M L West, Lucinda Billingham, Piers Gaunt, Martin Robinson
Publikováno v:
Radiotherapy and Oncology. 152:S39-S40
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93f30a57704d565f16bd370409ffcbe3
https://doi.org/10.1016/s0167-8140(21)00112-2
https://doi.org/10.1016/s0167-8140(21)00112-2
Autor:
N. Thiruthaneeswaran, Catharine M L West, Robert G. Bristow, Elisabet More, Ananya Choudhury, Becky A.S. Bibby, Ronnie Rodrigues Pereira
Publikováno v:
Radiotherapy and Oncology. 152:S167-S168
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9fe8f56f34f70b40207fe20b7fcdc569
https://doi.org/10.1016/s0167-8140(21)00343-1
https://doi.org/10.1016/s0167-8140(21)00343-1
Autor:
Catharine M L West, Elisabet More, James P Wylie, Ronnie Rodrigues Pereira, Helen Denley, Robert G. Bristow, A Henry, Becky A.S. Bibby, Nijula Thiruthaneeswaran, Ananya Choudhury, Peter Hoskin
Publikováno v:
Radiotherapy and Oncology. 152:S1086-S1087
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7894372de6fdd88b993947e3f74f1ebf
https://doi.org/10.1016/s0167-8140(21)01970-8
https://doi.org/10.1016/s0167-8140(21)01970-8
Autor:
Margaret R. Dunne, Becky A.S. Bibby, Maria Davern, Breandán N. Kennedy, Amy M. Buckley, Stephen G. Maher, Jacintha O'Sullivan, Susan Kennedy
Publikováno v:
Pharmaceuticals, Vol 12, Iss 1, p 33 (2019)
Pharmaceuticals
Volume 12
Issue 1
Pharmaceuticals
Volume 12
Issue 1
Cisplatin (cis-diamminedichloroplatinum) is widely used for the treatment of solid malignancies
however, the development of chemoresistance hinders the success of this chemotherapeutic in the clinic. This study provides novel insights into the m
however, the development of chemoresistance hinders the success of this chemotherapeutic in the clinic. This study provides novel insights into the m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4b285d1f24aec194b1db2830645ea5c
https://www.mdpi.com/1424-8247/12/1/33
https://www.mdpi.com/1424-8247/12/1/33
Autor:
Becky A.S. Bibby, Gillian M. Tozer, Tooba Alizadeh, Stephen Metcalf, Emily G. Wholey, Adriana Bucur, Martyn N.J. Paley, L. J. Williams, Samira Kazan, Joanne E. Bluff, Steven Reynolds
Publikováno v:
Radiotherapy and Oncology
Purpose To estimate the rate constant for pyruvate to lactate conversion in tumours in response to a hypoxic challenge, using hyperpolarised 13C1-pyruvate and magnetic resonance spectroscopy. Methods and materials Hypoxic inspired gas was used to man
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ce0251da7b70d2c2cbc4828996d981a
Autor:
Becky A.S. Bibby, Katherine B. Geiersbach, Stephen G. Maher, Christian N. Paxton, Mary P. Bronner, Laure Marignol, John V. Reynolds, Jacintha O'Sullivan, Niamh Lynam-Lennon, Ann Marie Mongan
Publikováno v:
Molecular Medicine, Vol 22, Iss 1, Pp 388-397 (2016)
Esophageal adenocarcinoma (EAC) has a poor prognosis and is increasing in incidence in many Western populations. Neoadjuvant chemoradiation therapy (CRT) followed by surgery is increasingly the standard of care for locally advanced EAC; however, resi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41ca9362da8f54b2d13114af3e41f94f
https://europepmc.org/articles/PMC5072404/
https://europepmc.org/articles/PMC5072404/
Autor:
T. Carroll, Michelle Osborne, David E. Neal, Charles E. Massie, Ian G. Mills, Becky A.S. Bibby, Patrick H. Maxwell, F. Lo, H Scott, D. Shukla, Anne Y. Warren, Maxine G. B. Tran, James Hadfield, Rory Stark, Lingjian Yang, Antonio Ramos-Montoya, Catharine M L West
Publikováno v:
Radiotherapy and Oncology. 127:S1268
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3697ee42eddedba318371f28c7867a2c
https://doi.org/10.1016/s0167-8140(18)32607-0
https://doi.org/10.1016/s0167-8140(18)32607-0
Publikováno v:
PLoS ONE
PLoS ONE, Vol 10, Iss 7, p e0134180 (2015)
PLoS ONE, Vol 10, Iss 7, p e0134180 (2015)
Oesophageal adenocarcinoma (OAC) is the sixth most common cause of cancer deaths worldwide, and the 5-year survival rate for patients diagnosed with the disease is approximately 17%. The standard of care for locally advanced disease is neoadjuvant ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43bbf90185aba0966c544006b456f402
http://europepmc.org/articles/PMC4519309
http://europepmc.org/articles/PMC4519309